Elton Carreiro Da Cunha

Elton Carreiro Da Cunha

Auto-generated profile, based on publicly available information

Elton Carreiro Da Cunha

Hospital Universitario Marqués de Valdecilla, IDIVAL, University of Cantabria, Santander, Spain

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 October 2022 in Forensic Science, Medicine and Pathology
Verified
Journal Article
Closed access
PDF file
ECElton Carreiro Da Cunha
Elton Carreiro Da Cunha
LMLucia Ordóñez Mayán
Lucia Ordóñez Mayán
MVMáximo Lucio Rodríguez Vázquez
Máximo Lucio Rodríguez Vázquez
NDNuno Vieira Duarte
Nuno Vieira Duarte
MFManuel Febrero-Bande
Manuel Febrero-Bande
JBJosé Ignacio Muñoz Barús
José Ignacio Muñoz Barús

19 January 2026 in The International Journal of Cardiovascular Imaging
Verified
Journal Article
Closed access
PDF file
ACAdrián Margarida de Castro
Adrián Margarida de Castro
JZJon Zubiaur
Jon Zubiaur
RPRaquel Pérez-Barquín
Raquel Pérez-Barquín
MGManuel Lozano González
Manuel Lozano González
GGGonzalo Martín Gorría
Gonzalo Martín Gorría
JTJosé Antonio Vázquez de Prada Tiffe
José Antonio Vázquez de Prada Tiffe

31 December 2025 in Heart
Verified
Journal Article
Closed access
ECElton Carreiro Da Cunha
Elton Carreiro Da Cunha
IOItziar Cucurull Ortega
Itziar Cucurull Ortega
MSMiriam Rodríguez de Rivera Socorro
Miriam Rodríguez de Rivera Socorro
LPLucía Muñoz Prejigueiro
Lucía Muñoz Prejigueiro
LSLucía Abia Sarriá
Lucía Abia Sarriá
CVCristina Ruisanchez Villar
Cristina Ruisanchez Villar
Background: Exercise stress echocardiography (ESE) is widely used to detect inducible myocardial ischaemia. However, a substantial proportion of ESEs remains inconclusive or shows abnormal non-ischaemic findings (fixed regional wall motion abnormalities without new inducible ischaemia), often requiring further testing. Baseline characteristics differ markedly between these groups, highlighting the need for studies that precisely adjust for confounders. This article aims to assess long-term outcomes among patients with negative, non-diagnostic or abnormal non-ischaemic ESE using robust confounder adjusted analyses. Methods: This was a retrospective cohort study conducted between 2017 and 2023 at a tertiary care hospital in Santander, northern Spain. Patients with inducible ischaemia or non-treadmill protocols were excluded. Participants were classified as diagnostic negative (≥85% predicted heart rate), non-diagnostic negative (<85%) or abnormal non-ischaemic (fixed wall motion abnormalities without inducible ischaemia). The primary endpoint was a composite of all-cause mortality, cardiovascular death, ischaemic hospitalisation and coronary angiography. Inverse probability of treatment weighting (IPTW) and generalised pairwise comparisons (GPC) assessed outcomes. Results: During a mean follow-up of 71 months among 788 patients, the overall event rate was 3.2 per 100 patient-years. Adjusted Cox models showed no significant differences between non-diagnostic (HR 0.92; 95% CI 0.49 to 1.72) or abnormal non-ischaemic (HR 0.80; 95% CI 0.24 to 2.61) versus diagnostic negative groups. Independent risk predictors included type 2 diabetes mellitus (HR 2.13; 95% CI 1.13 to 4.03) and lower ejection fraction (HR 0.97 per 1% increase; 95% CI 0.94 to 0.99). GPC identified more angiographies in the negative non-diagnostic group (p=0.04) and greater mortality in the abnormal non-ischaemic group (p=0.02) than in diagnostic negative patients, despite similar composite outcomes. Conclusion: Negative ESE generally predicts low risk; however, non-diagnostic or abnormal non-ischaemic GPC findings show subtle prognostic differences undetected by conventional analysis. These subgroups may warrant closer follow-up or additional imaging.